Biomerica (BMRA) vs WORK Medical Technology Group LTD (WOK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Biomerica is the larger company by market cap ($8.4 million vs $6.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BMRA | WOK |
|---|---|---|
| Share price | $1.84 | $1.54 |
| Market cap | $8.44M | $6.88M |
| 1-day change | -1.86% | +1.31% |
| YTD return | -25.00% | — |
| 1-year return | -34.38% | — |
| 5-year return | -95.74% | — |
| Forward P/E | 4.71 | — |
| EPS (TTM) | $-1.30 | $-51,993.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.21 | $98,000.00 |
| 52-week low | $1.45 | $1.40 |
| Distance from 52-week high | -42.83% | -100.00% |
| Average volume | 70.88K | 450.63K |
| Shares outstanding | 4.60M | 4.42M |
| Employees | 50 | 238 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Biomerica
BMRA stock →Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolerances, and other medical conditions, as well as detect and measure the presence and levels of specific bacteria, hormones, antibodies, antigens, and other substances that may exist in the human body at extremely low concentrations through clinical laboratories and in point-of-care settings, including physicians' offices and over-the-counter channels.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 50 employees
About WORK Medical Technology Group LTD
WOK stock →WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators.
Health Care · Medical/Dental Instruments · 238 employees
BMRA vs WOK FAQ
Which is bigger, Biomerica or WORK Medical Technology Group LTD?
Biomerica (BMRA) is larger, with a market capitalization of $8.44M compared with $6.88M for WORK Medical Technology Group LTD (WOK).
Are Biomerica and WORK Medical Technology Group LTD in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: In Vitro & In Vivo Diagnostic Substances for Biomerica and Medical/Dental Instruments for WORK Medical Technology Group LTD.